Clinical Trials on Mildly Hypercholesterolemic Subjects

Total 4682 results

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

A Study to Evaluate the Drug-drug Interactions (DDIs) of DBPR108 With Warfarin Sodium, Digoxin, Probenecid in Healthy Subjects

Healthy Subjects

China
BioVersys SAS

Completed

Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of BV100 in Male Subjects

Healthy Subjects

Germany
Vigonvita Life Sciences

Completed

Food Effect on Pharmacokinetic Profiles of VV116 Administered Orally to Chinese Healthy Volunteers

Healthy Subjects

China
NVP Healthcare

Completed

Evaluation of Pharmacokinetic and Safety of NVP-2102 and NVP-2102-R in Healthy Subjects

Healthy Subjects

Korea, Republic of
TWi Biotechnology, Inc.

Completed

Tofacitinib Citrate Topical Gel 3.2% FDA BA Bridging Study

Healthy Subjects

Canada
Heptares Therapeutics Limited

Completed

Comparison of Blood Levels of HTL0016878 From an Oral Capsule and an Oral Solution

Healthy Subjects

United Kingdom
Jiangsu HengRui Medicine Co., Ltd.

Completed

The PK/PD Study of SHR7280 Tablets in Healthy Subjects.

Healthy Subjects

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Food Effect Study of Apatinib Mesylate in Healthy Subjects

Healthy Subjects

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

Effect of Fluconazole on the Pharmacokinetics of Pyrotinib in Healthy Subjects

Healthy Subjects

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

Effect of Rifampicin on the Pharmacokinetics of SHR6390 in Healthy Subjects

Healthy Subjects

China
Nestlé

Completed

Effects of Enzymatic Digestion and Probiotic on Oleuropein Bioavailability

Healthy Subjects

Spain
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Completed

Bioequivalence of Dapagliflozin 10 mg Tablets Under Fasting Conditions

Healthy Subjects

Canada
Heptares Therapeutics Limited

Completed

Measurement of HTL0016878 in Cerebrospinal Fluid

Healthy Subjects

United Kingdom
Danone Research

Completed

Stools and Life Habits Collection in Heathy Volunteers/Subjects - to Provide Material for in Vitro Model Development (PEPSIIN)

Healthy Subjects

France
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study to Assess The Effects Of Effexor XR On Cardiac Repolarization In Healthy Adult Subjects

Healthy Subjects

United States
Tianjin SinoBiotech Ltd.

Completed

Study on Single Administration and Dose Increment of Recombinant Human Serum Albumin/Erythrocyte Fusion Protein for Injection

Healthy Subjects

China
Celldex Therapeutics

Completed

A Phase 1 Study of CDX-0159

Healthy Subjects

United States
Astellas Pharma Global Development, Inc.

Completed

A Study in Healthy Adult Volunteers to Assess the Safety and Pharmacokinetics of an Investigational Imaging Product

Healthy Subjects

United States
Nuance Pharma (shanghai) Co., Ltd

Completed

Evaluate the Pharmacokinetics and Safety of EXPAREL® Following Subcutaneous Administration in Healthy Chinese Subjects

Healthy Subjects

China
Tonix Pharmaceuticals, Inc.

Completed

Dose-Proportionality and Food Effect Study of TNX-102 SL

Healthy Subjects

Canada
Bausch Health Americas, Inc.

Completed

Pharmacokinetics and Bioavailability of Single Subcutaneous Doses of Methylnaltrexone Versus Intravenous Dose

Healthy Subjects

United States
Medtronic - MITG

Withdrawn

Definition and Validation of Normative Data of EndoFLIP™ Measurements in Healthy Subjects (RUBY)

Healthy Subjects
Inventiva Pharma
Parexel

Completed

Multiple Ascending Dose Phase I Study in Order to Define Lanifibranor (IVA337) Supra-thjerapeutic Dose (MAD)

Healthy Subjects

Germany
AstraZeneca

Completed

Pharmacokinetic Study of Benralizumab in Healthy Chinese Subjects

Healthy Subjects

Hong Kong
Seoul National University Hospital

Completed

Effect of Premeal Protein-bar on Food Intake

Healthy Subjects

Korea, Republic of
Helsinn Healthcare SA
Quotient Sciences

Completed

A Study In Healthy Male Volunteers Designed To Investigate How A Radiolabelled Medicine Is Broken Down And Removed From The Body

Healthy Subjects

United Kingdom
Fresenius Kabi SwissBioSim GmbH

Completed

MSB11022 in Healthy Subjects

Healthy Subjects
Reckitt Benckiser Inc.

Completed

Bioequivalence Study Comparing Mucinex Extended-release 600 mg Tablets to Immediate-release Guaifenesin 600 mg in Healthy Volunteers

Healthy Subjects
University of California, Davis

Completed

A Feasibility Study to Determine PET/CT Imaging of Blood Flow to the Bone (PETCT)

Normal Subjects

United States
Venatorx Pharmaceuticals, Inc.
National Institutes of Health (NIH)

Completed

Safety and Pharmacokinetics of VNRX-5133 in the Epithelial Lining Fluid of Healthy Adult Subjects

Healthy Subjects

United States
Astellas Pharma Inc

Completed

ASP8302 Single and Multiple Ascending Oral Dose Study in Non-elderly Healthy Japanese Subjects

Healthy Subjects

Japan
Reckitt Benckiser Inc.

Completed

Study to Characterize the Pharmacokinetics of 3 Marketed Products Containing 200 mg Guaifenesin in Healthy Volunteers.

Healthy Subjects
Pfizer

Completed

ESTIMATION OF THE EFFECT OF MULTIPLE DOSE PF-06651600 ON THE PHARMACOKINETICS OF SINGLE DOSE MIDAZOLAM AND EFAVIRENZ

Healthy Subjects

United States
Emergo Therapeutics, Inc.

Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Norketotifen in Healthy Subjects

Healthy Subjects

United States
Cortendo AB

Completed

Levoketoconazole Food Effect Study in Healthy Subjects

Healthy Subjects

United States
HK inno.N Corporation

Unknown

Bioequivalence Study of CJ-30060 in Healthy Volunteers

Healthy Subjects

Korea, Republic of
Eisai Inc.

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2027 in Healthy Subjects

Healthy Subjects

United States
Biogen

Completed

Safety, Tolerability, and Pharmacokinetics of Single Doses of BIIB059 in Healthy Japanese Subjects.

Healthy Subjects

United States
Trius Therapeutics LLC

Completed

A Phase 1 Crossover Study of Blood Pressure and Heart Rate Response

Healthy Subjects

United States
Pfizer

Completed

A Single Dose Crossover Study In Healthy Subjects To Evaluate Different Formulations Of PF-06882961

Healthy Subjects

United States
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Evaluate Cenerimod in Healthy Male Subjects

Healthy Subjects

Netherlands
Idorsia Pharmaceuticals Ltd.

Terminated

A Study to Evaluate if AC-084 is Safe, Its Fate in the Body as Well as Its Potential Effects on the Body in Healthy Subjects

Healthy Subjects

United Kingdom
Idorsia Pharmaceuticals Ltd.

Completed

Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-389949

Healthy Subjects

Netherlands
Azidus Brasil

Completed

Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Filgrastim (G-CSF)Produced by Blausiegel Indústria e Comércio Ltda. Compared to Granulokine Produced by Produtos Roche Químicos e Farmacêuticos S/A.

Healthy Subjects

Brazil
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Healthy Subjects
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Healthy Subjects
Pfizer

Completed

First In Human, Single Escalating Oral Dose Study Of PF-06882961 In Healthy Adult Subjects

Healthy Subjects

United States
Escola Superior de Tecnologia da Saúde do Porto

Completed

Neurophysiologic Effects of Cervical Spinal Manipulation in Asymptomatic Individuals

Healthy Subjects
Actelion

Completed

Clinical Study to Investigate Effect of Macitentan on Riociguat Pharmacokinetics

Healthy Subjects

Germany
Corvus Pharmaceuticals, Inc.

Completed

Study to Evaluate the Pharmacokinetics of a New Tablet Formulation of CPI-444 in Fed and Fasted Healthy Male and Female Subjects

Healthy Subjects

United States

3

Subscribe